MARTIN AIRCRAFT – IPO CASE STUDY
Axstra Capital was the sole lead advisor to the Martin Aircraft (ASX:MJP) IPO which listed on the ASX on the 24th Feb 2015.
Watch this case study video to learn the background behind the pre-IPO and IPO raising that brought in funds of over $33m for Martin Aircraft within 12 months.
POINT OF DIFFERENCE
Axstra Capital is not just a typical corporate advisory firm.
Rather than a straight fee for service offering, through the principals and our networks, we seek to work with companies that we can also invest into.
So rather than just working with anyone who will pay us, we are much more selective with the clients we take on.
We specifically seek to work with and invest into companies who meet the following criteria >>
braaap: Australian motorcycle designer, manufacturer, distributor and retailer.
BRiN: BRiN is a technology and business education company whose goal is to give millions of entrepreneurs and business owners a business advisor in their pocket. It utilises technology, artificial intelligence (AI), and education assets to provide business advisory services to millions of people simultaneously via an instant messaging interface on a smartphone app.
DomaCom Limited: DomaCom has developed a revolutionary, internet based investment platform and ASIC approved fund, the DomaCom Fund that enables investors to purchase “fractional interests” in specific properties of their choosing.
Jetpack Aviation: Jetpack Aviation, a company with operations based in Los Angeles CA, has created the world’s first true Jetpack – the JB-9. This compact Jetpack is powered by twin TurboJet engines. It is a true breakthrough in global aviation.
Mentor Education: Mentor Education Group is the largest privately owned and operated financial services training provider in Australia. Corporates and individuals seeking quality financial services training turn to Mentor Education for all their needs.
QBiotics Limited: QBiotics Limited is a QLD based life-science company that is developing drugs for the global cancer and wound healing markets. Axstra Capital has been advising QBiotics since 2010.